Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Johnson PharmacareBOM:532154 13 Current Ratio is 11.88 as of Mar. 2026, which is 68% below its 10-year median of 37.40. GuruFocus rates BOM:532154 with a GF Score™ of 13/100. The stock has 4 warning signs investors should review. Among 496 Diversified Financial Services companies, Johnson Pharmacare ranks better than 72.98% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Johnson Pharmacare's current ratio for the quarter that ended in Mar. 2026 was 11.88.
Johnson Pharmacare has a current ratio of 11.88. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Johnson Pharmacare's Current Ratio or its related term are showing as below:
BOM:532154'
s Current Ratio Range Over the Past 10 Years
Min: 0.96 Med: 37.4 Max: 5170.8
Current: 11.88
During the past 13 years, Johnson Pharmacare's highest Current Ratio was 5170.80. The lowest was 0.96. And the median was 37.40.
BOM:532154's Current Ratio is ranked better than 72.98% of 496
companies
in the Diversified Financial Services industry
Industry Median: 3.19
vs BOM:532154: 11.88
Johnson Pharmacare (BOM:532154) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Johnson Pharmacare Current Ratio Related Terms
Johnson Pharmacare Current Ratio Historical Data
* Premium members only.
The historical data trend for Johnson Pharmacare's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:532154 vs XXI, CCXI, DMII: Current Ratio Comparison
For the Shell Companies subindustry, Johnson Pharmacare's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Johnson Pharmacare Current Ratio vs Diversified Financial Services Industry
For the Diversified Financial Services industry and Financial Services sector, Johnson Pharmacare's Current Ratio distribution charts can be found below:
* The bar in red indicates where Johnson Pharmacare's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Johnson Pharmacare (BOM:532154) has a Current Ratio of 11.88 as of Mar. 2026. This is 68% below median its historical median of 37.40. Over the past decade, Johnson Pharmacare's Current Ratio has ranged from 0.96 to 5,170.80. According to the industry distribution chart, Johnson Pharmacare ranks #134 out of 496 companies in the Diversified Financial Services industry, placing it in the top 27%.
Is Johnson Pharmacare's Current Ratio too high?
Johnson Pharmacare's current Current Ratio of 11.88 is 68% below median its 10-year median of 37.40. Over the past 10 years, this metric has ranged from a low of 0.96 to a high of 5,170.80. The Diversified Financial Services industry median Current Ratio is 3.19. Johnson Pharmacare's value of 11.88 is 272.4% above this industry median. Based on the distribution chart, Johnson Pharmacare ranks #134 out of 496 companies in the Diversified Financial Services industry, which is above the industry midpoint. Overall, Johnson Pharmacare has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Johnson Pharmacare's Current Ratio compare to XXI and CCXI?
According to the Diversified Financial Services industry distribution chart, Johnson Pharmacare ranks #134 out of 496 companies for Current Ratio. This puts Johnson Pharmacare in the upper half of its industry. The industry median Current Ratio is 3.19. Johnson Pharmacare's value of 11.88 is 272.4% above this benchmark. Historically, Johnson Pharmacare's own Current Ratio has ranged from 0.96 to 5,170.80 over the past decade. While the company's 10-year median is 37.40 vs. the industry median of 3.19, Johnson Pharmacare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Diversified Financial Services company?
The median Current Ratio among Diversified Financial Services companies is 3.19, based on 496 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Johnson Pharmacare's current Current Ratio of 11.88 is 272.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Diversified Financial Services industry, the median Current Ratio is 3.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Johnson Pharmacare's current Current Ratio is 11.88, which is 68% below median its own 10-year median of 37.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Johnson Pharmacare stock overvalued right now?
Johnson Pharmacare (BOM:532154) has a current Current Ratio of 11.88. The current Current Ratio is 11.88, which is 68% below median its 10-year median of 37.40 and 272.4% above the Diversified Financial Services industry median of 3.19. Johnson Pharmacare's overall GF Score™ is 13/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Johnson Pharmacare (BOM:532154), the current Current Ratio is 11.88 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532154 has been successfully added to your 
